Skip to main content
. 2021 Aug 27;8:721174. doi: 10.3389/fmed.2021.721174

Figure 1.

Figure 1

Mesenchymal stem/stromal cell (MSC)-based cytokine delivery for tumor immunotherapy. Human MSCs upon procurement from various sources, such as bone marrow (BM), adipose tissue, and umbilical cord (UC), can be modified to express therapeutic genes (e.g., cytokines) for exerting antitumor response in patients suffering from tumors.